EcoDrugPlus

Natriuretic Peptide Receptor 2

Ensembl ID : ENSSARG00000003256
Gene Symbol: NPR2
1 External references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSSARG00000010602
Gene Symbol: NPR3
1 External references
211 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSSARG00000000252
Gene Symbol: NPY2R
3 External references
246 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSSARG00000010642
Gene Symbol: NPY5R
3 External references
135 Possible Orthologues:

Neuropeptide Y Receptor Type 4

Ensembl ID : ENSSARG00000002146
Gene Symbol: LOC101558149
2 External references
116 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSSARG00000005214
Gene Symbol: NTRK2
1 External references
286 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSSARG00000014368
Gene Symbol: NAMPT
1 External references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSSARG00000000541
Gene Symbol: NISCH
1 External references
209 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSSARG00000000594
Gene Symbol: NOS2
1 External references
163 Possible Orthologues:

Nuclear Factor Kappa B Subunit 2

Ensembl ID : ENSSARG00000006180
Gene Symbol: NFKB2
1 External references
124 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 3

Ensembl ID : ENSSARG00000002403
Gene Symbol: NR1H3
1 External references
391 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 1

Ensembl ID : ENSSARG00000000617
Gene Symbol: NR3C1
1 External references
278 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).